ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 822 filers reported holding ISHARES TR in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,433,243 | +15.2% | 207,936 | +19.6% | 0.04% | -5.0% |
Q2 2023 | $22,075,755 | +4.1% | 173,847 | +5.9% | 0.04% | 0.0% |
Q1 2023 | $21,202,421 | -45.6% | 164,090 | -44.8% | 0.04% | -49.4% |
Q4 2022 | $39,006,425 | +92.4% | 297,055 | +71.4% | 0.08% | +71.7% |
Q3 2022 | $20,271,000 | -3.3% | 173,302 | -2.6% | 0.05% | 0.0% |
Q2 2022 | $20,961,000 | -25.9% | 178,001 | -15.2% | 0.05% | -16.4% |
Q1 2022 | $28,273,000 | -29.5% | 210,008 | -20.0% | 0.06% | -27.6% |
Q4 2021 | $40,080,000 | +10.9% | 262,599 | +17.5% | 0.08% | +1.3% |
Q3 2021 | $36,125,000 | -6.8% | 223,478 | -5.6% | 0.08% | -10.7% |
Q2 2021 | $38,761,000 | -6.6% | 236,777 | -14.1% | 0.08% | -16.0% |
Q1 2021 | $41,512,000 | +10.6% | 275,650 | +11.2% | 0.10% | 0.0% |
Q4 2020 | $37,547,000 | +10.5% | 247,829 | -1.2% | 0.10% | -2.0% |
Q3 2020 | $33,978,000 | +8.0% | 250,895 | +9.0% | 0.10% | -3.8% |
Q2 2020 | $31,457,000 | +99.6% | 230,129 | -42.2% | 0.11% | +63.1% |
Q1 2020 | $15,757,000 | – | 397,885 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |